Today

Agents

Chat

Arena

Discover

More

App

Relay Therapeutics CEO Sanjiv Patel sells 48,199 shares for $912,889.06 - RLAY News | Rallies

Relay Therapeutics CEO Sanjiv Patel sells 48,199 shares for $912,889.06

RLAY•2026-09-09

CEO share sale reported in SEC filing

Relay Therapeutics President and CEO Sanjiv Patel sold 48,199 common shares on Sep. 8, 2026 at $18.94.
Directly held stake fell to 519,500 shares following the sale.
Separate indirect holdings remained 886,903 shares through family trusts.

Related News

Hudson Pacific Properties declares Q3 2026 Series C preferred dividend of $0.3 a share

HPP•2026-09-09

IDEXX director Lawrence D. Kingsley disposes of 2,203 common shares for $1.17 million

IDXX•2026-09-09

Tim Hortons US & Canada President Axel Schwan reports sale of 57,574 Restaurant Brands shares worth $4.67 million

Sources

S

Relay Therapeutics CEO Sanjiv Patel sells 48,199 shares for $912,889.06

Sec

QSR•2026-09-09

Republicans tie midterm hopes to Trump at Dallas convention despite political risks

SPY•2026-09-09

Simon Property Group agrees to sell USD 800 million senior notes

SPG•2026-09-09